Elderly aortic stenosis patients live longer with minimally invasive valve replacement
Study compared TAVR outcomes to standard therapy
2015-03-15
(Press-News.org) Sunday, March 15, 2015, San Diego: Elderly patients once considered too frail or tool sick for aortic valve replacement surgery are living longer, with better quality of life, following a minimally invasive surgery, compared to patients who did not undergo surgery, according a study published in The Lancet today.
Researchers at 21 medical centers followed 358 patients with severe aortic stenosis for five years. The patients, with a mean age of 83, were evenly divided into two study groups - one that underwent minimally invasive transcatheter aortic valve replacement (TAVR) surgery and one that followed standard therapy, which involved balloon aortic valvuloplasty but no surgery.
Those undergoing TAVR lived longer, with better symptom management, fewer hospital readmissions and better functional status. At the five-year mark, 28.2 percent of the TAVR group were still alive, compared to only 6.4 percent of those undergoing standard therapy.
"This trial is the first--and will probably be the only--randomized aortic stenosis trial that includes a group of patients not treated with aortic valve replacement, since these results will make it unethical to treat severe aortic stenosis patients with medical therapy alone," said Samir Kapadia, M.D., the study's primary author and director of the Sones Cardiac Catheterization Laboratories at Cleveland Clinic.
Aortic stenosis is the most common heart valve disease, causing the aortic valve not to open fully and decreasing blood flow from the heart. For decades, the gold standard treatment was considered aortic valve replacement, though many older patients in their 80s and 90s were considered too sick or too frail to undergo the rigorous surgery. For those patients, TAVR became an option. This study was the first to compare five-year TAVR outcomes with standard therapy.
INFORMATION:
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S.News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. More than 3,000 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. The Cleveland Clinic health system includes a main campus near downtown Cleveland, eight community hospitals, more than 75 Northern Ohio outpatient locations, including 16 full-service Family Health Centers, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Cleveland Clinic Canada, and, scheduled to begin seeing patients in 2015, Cleveland Clinic Abu Dhabi. In 2013, there were 5.5 million outpatient visits throughout the Cleveland Clinic health system and 157,000 hospital admissions. Patients came for treatment from every state and from more than 130 countries. Visit us at http://www.clevelandclinic.org. Follow us at http://www.twitter.com/ClevelandClinic.
ELSE PRESS RELEASES FROM THIS DATE:
2015-03-15
New Haven, Conn. -- In the first multicenter trial of its kind, Yale researchers tested a new device that lowers the risk of stroke and cognitive decline in patients undergoing heart-valve replacement.
The preliminary findings of the DEFLECT III trial were presented by Alexandra Lansky, M.D., associate professor of medicine (cardiology) at Yale School of Medicine, on March 15 at the American College of Cardiology's 64th Annual Scientific Session in San Diego, CA.
Stroke is a devastating complication of transcatheter aortic valve replacement (TAVR), a minimally invasive ...
2015-03-15
In a study that included more than 20,000 adults in China with high blood pressure but without a history of stroke or heart attack, the combined use of the hypertension medication enalapril and folic acid, compared with enalapril alone, significantly reduced the risk of first stroke, according to a study appearing in JAMA. The study is being released to coincide with its presentation at the American College of Cardiology Annual Scientific Session.
Stroke is the leading cause of death in China and second leading cause of death in the world. Primary prevention (prevention ...
2015-03-14
Boston, Mass., USA - Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Olivier Duverger, National Institutes of Health-National Institute of Neurological Disorders and Stroke, Bethesda, Md., USA, will present a study titled "Hair Keratins as Structural Organic Components of Mature Enamel: The Link Between Hair Disorders and Susceptibility to Dental Caries." The IADR General Session is being held in conjunction with the 44th Annual Meeting of the American Association for Dental Research and the 39th Annual Meeting ...
2015-03-14
Estoril, Portugal: Researchers in the UK have, for the first time, shown how exhaust pollution from diesel engines is able to affect nerves within the lung. Air pollution is a significant threat to health, they say, and identifying potential mechanisms linking exposure to diesel exhaust and the exacerbation of respiratory diseases may lead to treatments for those affected.
Mr. Ryan Robinson, a PhD student at the National Heart and Lung Institute, Imperial College London, UK, will tell the 13th European Respiratory Society Lung Science Conference today (Saturday) about ...
2015-03-13
BUILDINGS -- Shielding against energy loss ...
Air seeping from buildings is responsible for a large amount of wasted energy each year. To combat the problem, researchers at Oak Ridge National Laboratory collaborated with the Dow Chemical Company to develop a sprayable liquid flashing that is more cost-effective than traditional sealing materials such as peel-and-stick tapes. The new technology can be used in residential and commercial construction, and its ease of use results in increased energy savings and decreased labor and installation costs. Additionally, the liquid ...
2015-03-13
COLUMBUS, OHIO and FORT WASHINGTON, PA -- Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States--more than 25 percent--will be caused by tobacco smoking.
To meet the needs of patients who are smokers at the time of a cancer diagnosis, the National Comprehensive Cancer Network® (NCCN®) has published the NCCN Clinical ...
2015-03-13
A work group of physicians from leading academic medical centers across the country, including NYU Langone Medical Center, has developed new quality measures for the detection and treatment of childhood obstructive sleep apnea (OSA), a potentially morbid, life-altering condition that affects hundreds of thousands of children and adolescents nationwide. The measures, commissioned and endorsed by the American Association of Sleep Medicine (AASM), are published on March 15 in a special section of The Journal of Clinical Sleep Medicine.
Several different practice guidelines ...
2015-03-13
DARIEN, IL - Today the American Academy of Sleep Medicine (AASM) published new quality measures for five common sleep disorders, which represents a landmark achievement in the promotion of high quality, patient-centered care in the medical subspecialty of sleep medicine.
The summary paper, "Measurement of Quality to Improve Care in Sleep Medicine," is published in the March issue of the Journal of Clinical Sleep Medicine along with five workgroup papers presenting outcome and process measures to aid in evaluating the quality of care of restless legs syndrome, insomnia, ...
2015-03-13
TORONTO, March 13, 2015 - York University researchers have learned how living beings can keep gene expression in check -- which might partly explain the uncontrolled gene expression found in many cancers.
"Using yeast as a model organism, we studied the Tup1 protein, a negative regulator of gene expression," says Biology Professor Emanuel Rosonina, adding, "This protein binds to some genes and blocks their expression, helping to ensure genes that shouldn't be turned on remain inactive."
The current study, jointly conducted by York University and Columbia University ...
2015-03-13
New York, NY--March 23, 2015--A team of Columbia Engineering researchers has invented a technology--full-duplex radio integrated circuits (ICs)--that can be implemented in nanoscale CMOS to enable simultaneous transmission and reception at the same frequency in a wireless radio. Up to now, this has been thought to be impossible: transmitters and receivers either work at different times or at the same time but at different frequencies. The Columbia team, led by Electrical Engineering Associate Professor Harish Krishnaswamy, is the first to demonstrate an IC that can accomplish ...
LAST 30 PRESS RELEASES:
[Press-News.org] Elderly aortic stenosis patients live longer with minimally invasive valve replacement
Study compared TAVR outcomes to standard therapy